Action 300039 SHANGHAI KAIBAO PHARMACEUTICAL CO.,LTD
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Shanghai Kaibao Pharmaceutical CO.,Ltd

Actions

300039

CNE100000JZ3

Cours en clôture Shenzhen S.E.
Autres places de cotation
 00:00:00 01/07/2024 		Varia. 5j. Varia. 1 janv.
5,41 CNY +1,12% Graphique intraday de Shanghai Kaibao Pharmaceutical CO.,Ltd -0,55% -18,65%
06/06 Shanghai Kaibao Pharmaceutical Co. approuve l'élection partielle de Wang Guoming en tant qu'administrateur non indépendant CI
25/04 Shanghai Kaibao Pharmaceutical CO.,Ltd publie ses résultats pour le premier trimestre clos le 31 mars 2024 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Shanghai Kaibao Pharmaceutical Co.,Ltd. Announces Cash Dividend on A Shares for Year 2023, Payable on June 19, 2024
Shanghai Kaibao Pharmaceutical Co.,Ltd Approves the By-Election of Wang Guoming as Non-Independent Director
Shanghai Kaibao Pharmaceutical Co.,Ltd Approves the Cash Dividend for the Year 2023
Shanghai Kaibao Pharmaceutical Co.,Ltd Proposes Final Dividend for the Year 2023
Shanghai Kaibao Pharmaceutical CO.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Shanghai Kaibao Pharmaceutical CO.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Maling Aquarius' President Resigns
Shanghai Kaibao Pharmaceutical CO.,Ltd Announces Executive Changes
Shanghai Kaibao Pharmaceutical CO.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
Shanghai Kaibao Pharmaceutical CO.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
Shanghai Kaibao Pharmaceutical Co.,Ltd. Approves Cash Dividend for 2022, Payable on 26 May 2023
Shanghai Maling Aquarius Names Chairman
Shanghai Kaibao Pharmaceutical CO.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Shanghai Kaibao Pharmaceutical Co.,Ltd Announces the Profit Distribution Proposal for 2022
Shanghai Kaibao Pharmaceutical CO.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2022
Shanghai Kaibao Pharmaceutical CO.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
Shanghai Kaibao Pharmaceutical CO.,Ltd(XSEC:300039) added to S&P Global BMI Index
Shanghai Kaibao Pharmaceutical CO.,Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
Shanghai Kaibao Pharmaceutical Co.,Ltd Announces Final Cash Dividend on A Shares for 2021, Payable on 16 June 2022
Shanghai Kaibao Pharmaceutical CO.,Ltd Approves Cash Dividend for the Year 2021
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action 300039
  4. Actualités Shanghai Kaibao Pharmaceutical CO.,Ltd
  5. Autres langues